Page last updated: 2024-09-03

thrombin receptor peptide sfllrnp and Heart Diseases

thrombin receptor peptide sfllrnp has been researched along with Heart Diseases in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Grgurevich, S; Jacoski, MV; Jennings, LK; Li, JS; Michelson, AD; Tyagi, A1
Harder, S; Klinkhardt, U1

Trials

1 trial(s) available for thrombin receptor peptide sfllrnp and Heart Diseases

ArticleYear
Pharmacodynamic effects of clopidogrel in pediatric cardiac patients: a comparative study of platelet aggregation response.
    Platelets, 2012, Volume: 23, Issue:6

    Topics: Adenosine Diphosphate; Adult; Arteries; Blood Platelets; Child, Preschool; Clopidogrel; Double-Blind Method; Female; Fetal Blood; Heart; Heart Diseases; Humans; Infant; Infant, Newborn; Male; Peptide Fragments; Placebos; Platelet Aggregation; Platelet Aggregation Inhibitors; Thrombosis; Ticlopidine

2012

Other Studies

1 other study(ies) available for thrombin receptor peptide sfllrnp and Heart Diseases

ArticleYear
Flow cytometric measurement of platelet-leukocyte aggregates: a possible target to monitor platelet function?
    Seminars in thrombosis and hemostasis, 2005, Volume: 31, Issue:4

    Topics: Adenosine Diphosphate; Adult; Arterial Occlusive Diseases; Aspirin; Blood Platelets; Clopidogrel; Flow Cytometry; Heart Diseases; Humans; Leukocytes; Male; Monocytes; Peptide Fragments; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Risk; Ticlopidine

2005